PROSPERiA is a healthtech company focused on democratizing healthcare access through Artificial Intelligence solutions. The core platform automatically analyzes retina images to prevent blindness. This analysis provides personalized recommendations for both patients and medical professionals.
Funding
$5.3B raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Late diagnosis of chronic diseases, particularly among diabetic patients, leads to preventable blindness due to conditions like diabetic retinopathy. Traditional methods for retinal image analysis often lack accessibility, hindering early detection and timely intervention.
Solution
PROSPERiA offers an AI-powered platform designed for the automatic analysis of retinal images, facilitating the early prevention of blindness. The platform analyzes images and generates personalized recommendations for both patients and doctors. By automating the analysis process, PROSPERiA aims to democratize access to quality healthcare and improve diagnostic efficiency. The solution enables timely monitoring and intervention, reducing the risk of vision loss associated with chronic diseases.
Target Audience
The primary target audience includes healthcare providers, ophthalmologists, and diabetic patients at risk of developing diabetic retinopathy.
Features
- AI-driven analysis of retinal images for automated detection of abnormalities.
- Personalized recommendations for patients and doctors based on the analysis.
- Cloud-based platform for accessibility and scalability.